Wang, F., Bank, T., Malnassy, G., Arteaga, M., Shang, N., Dalheim, A., . . . Qiu, W. (2018). Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival. Hepatol Commun.
Παραπομπή Chicago StyleWang, Fang, et al. "Inhibition of Insulin‐like Growth Factor 1 Receptor Enhances the Efficacy of Sorafenib in Inhibiting Hepatocellular Carcinoma Cell Growth and Survival." Hepatol Commun 2018.
Παραπομπή MLAWang, Fang, et al. "Inhibition of Insulin‐like Growth Factor 1 Receptor Enhances the Efficacy of Sorafenib in Inhibiting Hepatocellular Carcinoma Cell Growth and Survival." Hepatol Commun 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.